Tags: diabetes

8/16/2018

Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier

6/22/2018

One blood test to diagnose diabetes? HealthDay doesn’t address harms of overdiagnosis and overtreatment

5/31/2018

LA Times provides careful take on early brain/diabetes research–except for the headline

3/5/2018

NPR story about online weight loss program left out a key detail: How much does it cost?

12/7/2017

When weight loss is the intervention, it’s still important to talk about costs and harms

10/3/2017

AP’s write-up on a new continuous blood sugar monitor–where’s the proof that it works?

3/13/2017

Can these 10 foods really ‘cut risk of early death’? NPR overstates the evidence

6/16/2016

Independent source and costs: All that’s missing from otherwise solid Reuters story on Victoza

5/23/2016

Guardian predicts end to insulin shots based on rehashed news release, mouse research

5/20/2016

Reuters story on oral insulin trial needed sources beyond drug company CEO

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

Retweet on TwitterHealthNewsReview.org Retweeted
AKECasselsAlan Cassels@AKECassels·

Puleeeeease... this 'game changer' weight loss drug causes more nausea and vomiting than a placebo. Some game, some change. My friend Gary would spank you for using the eighth word medical reporters should never, ever use. @garyschwitzer @thackerpd
https://www.healthnewsreview.org/toolkit/just-journalists-writing-tips-case-studies/7-words-and-more-you-shouldnt-use-in-medical-news/ https://twitter.com/OttawaCitizen/status/1361426796126830597

Reply on Twitter 1361431489326407680Retweet on Twitter 13614314893264076806Like on Twitter 13614314893264076808Twitter 1361431489326407680
Retweet on TwitterHealthNewsReview.org Retweeted
RxISKRxISK@RxISK·

A scary @statnews Op-Ed warns that govt attempts to rein in Pharma may cut off access to "life-changing" drugs.

It takes @garyschwitzer to let us know: the author spent 10 years as Pfizer's public-policy chief. https://twitter.com/garyschwitzer/status/1360325022578053123

Reply on Twitter 1361420459284131843Retweet on Twitter 13614204592841318439Like on Twitter 136142045928413184319Twitter 1361420459284131843
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532Retweet on Twitter 13602149497049825325Like on Twitter 136021494970498253210Twitter 1360214949704982532
View More

Categories

View More

Tags